Ingenus Pharmaceuticals
As Chairman & CEO of Ingenus Pharmaceuticals, Mr. Mantena is a career innovator responsible for providing overall leadership and strategic direction for the business. Prior to creating Ingenus Pharmaceuticals, he founded ICORE Healthcare, a company that provides health plans with solutions to manage specialty cost trends. Prior to ICORE, he founded International Oncology Network (ION), an oncology group purchasing organization, and OncoScripts, one of the first oncology focused specialty pharmacies.
Mr. Mantena earned his degree in clinical pharmacy from the University of Maryland and a bachelor’s degree in computer science and engineering from JNTU (Jawaharlal Nehru Technological University) in India.
This person is not in any offices
Ingenus Pharmaceuticals
1 followers
Ingenus Pharmaceuticals is an emerging privately held U.S. based generic pharmaceutical company with manufacturing and research and development facilities in the U.S.,Switzerland, and India. Since 2010, Ingenus has been developing, manufacturing and commercializing quality generic medications as cost effective solutions for patients and suppliers. With over 65 filings covering a wide range of therapeutic classes ,including transdermal, parenteral, semi-solids, injectable, and extended release products Ingenus is well positioned to becoming a leader in the generic pharmaceutical industry.